CD10 expression in the neuroendocrine carcinoma component of endometrial mixed carcinoma: association with long survival

详细信息    查看全文

• 作者：Karina Uehara ; Fukino Ikehara ; Yasuka Tanabe ; Iwao Nakazato…
• 关键词：Endometrial mixed carcinoma ; Neuroendocrine carcinoma ; Well differentiated endometrioid adenocarcinoma ; CD10 ; PTEN ; Long survival
• 刊名：Diagnostic Pathology
• 出版年：2016
• 出版时间：December 2016
• 年：2016
• 卷：11
• 期：1
• 全文大小：2,334 KB
• 参考文献：1.Zaino R, Matias-Guiu X, Carinelli SG, Mutter GL, Ellenson LH, Peters III WA, et al. Tumors of the uterine corpus. In: Kurman RJ, Carcangiu ML, Herrington CS, Young RH, editors. WHO Classification of Tumours of Female Reproductive Organs. 4th ed. Lyon: International Agency for Research on Cancer (IARC); 2014. p. 132.
  2.Huntsman DG, Clement PB, Gilks CB, Scully RE. Small-cell carcinoma of the endometrium. A clinicopathological study of sixteen cases. Am J Surg Pathol. 1994;18:364–75.CrossRef PubMed
  3.Eichhorn JH, Young RH. Neuroendocrine tumors of the genital tract. Am J Clin Pathol. 2001;115(Suppl):S94–112.PubMed
  4.Atienza-Amores M, Guerini-Rocco E, Soslow RA, Park KJ, Weigelt B. Small cell carcinoma of the gynecologic tract: a multifaceted spectrum of lesions. Gynecol Oncol. 2014;134:410–8.CrossRef PubMed
  5.Mulvany NJ, Allen DG. Combined large cell neuroendocrine and endometrioid carcinoma of the endometrium. Int J Gynecol Pathol. 2008;27:49–57.CrossRef PubMed
  6.Katahira A, Akahira J, Niikura H, Ito K, Moriya T, Matsuzawa S, et al. Small cell carcinoma of the endometrium: report of three cases and literature review. Int J Gynecol Cancer. 2004;14:1018–23.CrossRef PubMed
  7.Albores-Saavedra J, Martinez-Benitez B, Luevano E. Small cell carcinomas and large cell neuroendocrine carcinomas of the endometrium and cervix: polypoid tumors and those arising in polyps may have a favorable prognosis. Int J Gynecol Pathol. 2008;27:333–9.CrossRef PubMed
  8.Sato H, Kanai G, Kajiwara H, Itoh J, Osamura RY. Small-cell carcinoma of the endometrium presenting as Cushing’s syndrome. Endocr J. 2010;57:31–8.CrossRef PubMed
  9.Matsumoto H, Takai N, Nasu K, Narahara H. Small cell carcinoma of the endometrium: a report of two cases. J Obstet Gynaecol Res. 2011;37:1739–43.CrossRef PubMed
  10.Maguer-Satta V, Besancon R, Bachelard-Cascales E. Concise review: neutral endopeptidase (CD10): a multifaceted environment actor in stem cells, physiological mechanisms, and cancer. Stem Cells. 2011;29:389–96.CrossRef PubMed
  11.Choi WW, Weisenburger DD, Greiner TC, Piris MA, Banham AH, Delabie J, et al. A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res. 2009;15:5494–502.CrossRef PubMed
  12.Terauchi M, Kajiyama H, Shibata K, Ino K, Mizutani S, Kikkawa F. Anti-progressive effect of neutral endopeptidase 24.11 (NEP/CD10) on cervical carcinoma in vitro and in vivo. Oncology. 2005;69:52–62.CrossRef PubMed
  13.Tokuhara T, Adachi M, Hashida H, Ishida H, Taki T, Higashiyama M, et al. Neutral endopeptidase/CD10 and aminopeptidase N/CD13 gene expression as a prognostic factor in non-small cell lung cancer. Jpn J Thorac Cardiovasc Surg. 2001;49:489–96.CrossRef PubMed
  14.Deschamps L, Handra-Luca A, O’Toole D, Sauvanet A, Ruszniewski P, Belghiti J, et al. CD10 expression in pancreatic endocrine tumors: correlation with prognostic factors and survival. Hum Pathol. 2006;37:802–8.CrossRef PubMed
  15.Velazquez EF, Yancovitz M, Pavlick A, Berman R, Shapiro R, Bogunovic D, et al. Clinical relevance of neutral endopeptidase (NEP/CD10) in melanoma. J Transl Med. 2007;5:2.PubMedCentral CrossRef PubMed
  16.Piattelli A, Fioroni M, Iezzi G, Perrotti V, Stellini E, Piattelli M, et al. CD10 expression in stromal cells of oral cavity squamous cell carcinoma: a clinic and pathologic correlation. Oral Dis. 2006;12:301–4.CrossRef PubMed
  17.La Rosa S, Sessa F, Capella C, Riva C, Leone BE, Klersy C, et al. Prognostic criteria in nonfunctioning pancreatic endocrine tumours. Virchows Arch. 1996;429:323–33.CrossRef PubMed
  18.Kloppel G. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms. Endocr Relat Cancer. 2011;18 Suppl 1:S1–16.CrossRef PubMed
  19.Delaloge S, Pautier P, Kerbrat P, Castaigne D, Haie-Meder C, Duvillard P, et al. Neuroendocrine small cell carcinoma of the uterine cervix: what disease? What treatment? Report of ten cases and a review of the literature. Clin Oncol (R Coll Radiol). 2000;12:357–62.CrossRef
  20.Weed Jr JC, Graff AT, Shoup B, Tawfik O. Small cell undifferentiated (neuroendocrine) carcinoma of the uterine cervix. J Am Coll Surg. 2003;197:44–51.CrossRef PubMed
  21.Walker AN, Mills SE, Taylor PT. Cervical neuroendocrine carcinoma: a clinical and light microscopic study of 14 cases. Int J Gynecol Pathol. 1988;7:64–74.CrossRef PubMed
  22.van Hoeven KH, Hudock JA, Woodruff JM, Suhrland MJ. Small cell neuroendocrine carcinoma of the endometrium. Int J Gynecol Pathol. 1995;14:21–9.CrossRef PubMed
  23.Abeler VM, Kjorstad KE, Nesland JM. Undifferentiated carcinoma of the endometrium. A histopathologic and clinical study of 31 cases. Cancer. 1991;68:98–105.CrossRef PubMed
  24.Rindi G, Klimstra DS, Arnold R, Kloppel G, Bosman FT, Komminoth P, et al. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: Bosman FT, Carneilo F, Hruban RH, Theise ND, editors. WHO Classification of Tumours of the Digestive System. Lyon: International Agency for Research on Cancer (IARC); 2010. p. 13–4.
  25.Goodman Jr OB, Febbraio M, Simantov R, Zheng R, Shen R, Silverstein RL, et al. Neprilysin inhibits angiogenesis via proteolysis of fibroblast growth factor-2. J Biol Chem. 2006;281:33597–605.CrossRef PubMed
  26.Sumitomo M, Shen R, Nanus DM. Involvement of neutral endopeptidase in neoplastic progression. Biochim Biophys Acta. 2005;1751:52–9.CrossRef PubMed
  27.Borowitz MJ, Devidas M, Hunger SP, Bowman WP, Carroll AJ, Carroll WL, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children’s Oncology Group study. Blood. 2008;111:5477–85.PubMedCentral CrossRef PubMed
  28.Dakka N, Bellaoui H, Bouzid N, Khattab M, Bakri Y, Benjouad A. CD10 AND CD34 expression in childhood acute lymphoblastic leukemia in Morocco: clinical relevance and outcome. Pediatr Hematol Oncol. 2009;26:216–31.CrossRef PubMed
  29.Langner C, Ratschek M, Rehak P, Schips L, Zigeuner R. CD10 is a diagnostic and prognostic marker in renal malignancies. Histopathology. 2004;45:460–7.CrossRef PubMed
  30.Tohya T, Miyazaki K, Katabuchi H, Fujisaki S, Maeyama M. Small cell carcinoma of the endometrium associated with adenosquamous carcinoma: a light and electron microscopic study. Gynecol Oncol. 1986;25:363–71.CrossRef PubMed
  31.Tenti P, Carnevali L, Paulli M, Franchi M, Babilonti L. Dedifferentiating endometrial adenocarcinoma. Report of a case. Eur J Gynaecol Oncol. 1989;10:292–4.PubMed
  32.Campo E, Brunier MN, Merino MJ. Small cell carcinoma of the endometrium with associated ocular paraneoplastic syndrome. Cancer. 1992;69:2283–8.CrossRef PubMed
  33.Sekiguchi I, Suzuki M, Sato I, Ohkawa T, Kawashima H, Tsuchida S. Rare case of small-cell carcinoma arising from the endometrium with paraneoplastic retinopathy. Gynecol Oncol. 1998;71:454–7.CrossRef PubMed
  34.Shaco-Levy R, Manor E, Piura B, Ariel I. An unusual composite endometrial tumor combining papillary serous carcinoma and small cell carcinoma. Am J Surg Pathol. 2004;28:1103–6.CrossRef PubMed
  35.Hwang JH, Lee JK, Lee NW, Lee KW. Primary small cell carcinoma of the endometrium: report of a case with immunochemical studies. J Reprod Med. 2010;55:81–6.PubMed
  36.Koo YJ, Kim DY, Kim KR, Kim JH, Kim YM, Kim YT, et al. Small cell neuroendocrine carcinoma of the endometrium: a clinicopathologic study of six cases. Taiwan J Obstet Gynecol. 2014;53:355–9.CrossRef PubMed
  
• 作者单位：Karina Uehara (1)
  Fukino Ikehara (1)
  Yasuka Tanabe (1)
  Iwao Nakazato (2)
  Mariko Oshiro (3)
  Morihiko Inamine (4)
  Takao Kinjo (1)
  
  1. Division of Morphological Pathology, Department of Basic Laboratory Sciences, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa, 903-0215, Japan
  2. Department of Pathology, Okinawa Prefectural Nanbu Medical Center & Children’s Medical Center, 118-1 Arakawa Haebaru, Okinawa, 901-1193, Japan
  3. Health Information Management Major, Faculty of International Studies, Meio University, 1220-1 Biimata, Nago, Okinawa, 905-8585, Japan
  4. Department of Medical Science of Woman and Reproduction, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa, 903-0215, Japan
  
• 刊物主题：Pathology;
• 出版者：BioMed Central
• ISSN：1746-1596

文摘

Backgound Endometrial mixed carcinoma with the neuroendocrine carcinoma (NEC) component is rare and is believed to have a poor prognosis. CD10 expression is reported to be a favorable prognostic marker for some tumors such as B-lymphoblastic leukemia/lymphoma, but unfavorable for others. Here, we report the case of a 33-year-old woman diagnosed with endometrial mixed carcinoma with the NEC component expressing CD10 who showed a favorable outcome.